Multiple sclerosis (MS) is a disorder of the brain and spinal cord. It can cause various symptoms. In most cases, episodes of symptoms come and go at first for several years. In time, some symptoms can become permanent and can cause disability. Although there is no cure for MS, various drugs and therapies may reduce the number of flare-ups and can help to ease symptoms and disability.
Zistdaru danesh as a pioneer of Iranian biotechnology industry was founded at pharmaceutical Incubator Center of Tehran Medical Science University in 2005. Since the earliest days, We had focus on the development of products to benefit people with Multiple sclerosis. Today, Ziferon® (interferon beta1b bio-similar product) and Tebazio® (Teriflunomide) are our main products and Teczifuma, another specific product for MS disease (Dimethyl fumarat), will be released in 2017. In 2016, our focus expanded to another programs in oncology field.